Steering Committee

The 13 members of the OxCD3 Steering Committee, listed below, are responsible for managing funding flexibility and reviewing funding allocation to Work Packages in light of recent clinical and industrial developments and the recommendations of the IAB.

Chair
University of Oxford
Academic clinician - cancer radiology
University of Oxford
Professor of medical oncology
University of Surrey
Academic clinician - cancer surgery
University of Oxford
Academic Clinician - Oncology
National Institutes of Health
Industrial member
Dr Dennis Lee
GSK
Industrial member
Dr Pavel Novak
Storz
Industrial member
OxSonics
Intellectual property representative
ISIS Innovation
MHRA representative
Ms Theresa Jeary
Lloyd's Register
Industrial member
Dr Christine Boehm
Siemens Healthineers
Industrial member
Dr Richard Green
Pfizer
EPSRC representative
Dr Stephanie Newland

 

© Copyright OXCD3 2016